newsfilter
← Latest News
PR Newswire·

Kuick Research Recognizes TC BioPharm as a Key Player in the Gamma-Delta T Cell Therapy Market

Sector is Expected to Surpass $4 Billion by 2028 Report Highlights Promising Therapy and Rising Investment from Pharmaceutical Companies EDINBURGH, Scotland, May 23, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NA